Skip to search formSkip to main contentSkip to account menu

mofezolac

Known as: (3,4-bis(4-methoxyphenyl)-5-isoxazolyl)acetic acid, (3,4-di-(4-methoxyphenyl)-5-isoxazolyl)acetic acid, 3,4-DMPIAA 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
As with cyclooxygenase (COX)‐2, genetic disruption of COX‐1 gene or pharmacologic inhibition of its activity has been shown to… 
2004
2004
Objective—Cyclooxygenase-1 (COX-1), but not COX-2, is expressed in human platelets, and thromboxane A2 (TXA2) produced via COX-1… 
2004
2004
AbstractObjective and design:The aim of this study was to confirm the involvement of cyclooxygenase (COX)-1 in rheumatoid… 
2002
2002
COX-2 is an inducible cyclooxygenase (COX) that has been reported to be expressed in the macula densa and surrounding cortical… 
1990
1990
Pharmacological activities of mofezolac were investigated in experimental animal models and compared with those of indomethacin… 
1990
1990
Mofezolac (N-22) is a new developed analgesic and anti-inflammatory agent. A subacute oral toxicity test of N-22 was carried out…